MedPath

Oxytocin

OXYTOCIN INJECTION, USP

Approved
Approval ID

d16a48c5-6b71-40a0-bcda-204f043fe832

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 14, 2018

Manufacturers
FDA

West-Ward Pharmaceuticals Corp

DUNS: 001230762

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Oxytocin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0143-9743
Application NumberANDA200219
Product Classification
M
Marketing Category
C73584
G
Generic Name
Oxytocin
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateSeptember 17, 2018
FDA Product Classification

INGREDIENTS (4)

OXYTOCINActive
Quantity: 10 [USP'U] in 1 mL
Code: 1JQS135EYN
Classification: ACTIB
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
CHLOROBUTANOLInactive
Quantity: 500 mg in 1 mL
Code: HM4YQM8WRC
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

Oxytocin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0143-9742
Application NumberANDA200219
Product Classification
M
Marketing Category
C73584
G
Generic Name
Oxytocin
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateSeptember 17, 2018
FDA Product Classification

INGREDIENTS (4)

OXYTOCINActive
Quantity: 10 [USP'U] in 1 mL
Code: 1JQS135EYN
Classification: ACTIB
CHLOROBUTANOLInactive
Quantity: 500 mg in 1 mL
Code: HM4YQM8WRC
Classification: IACT
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.